Abstract
G protein signaling is an extremely complex event that is involved in almost every cellular process. As such, G protein-coupled receptors are the most commonly found type of transmembrane receptors used by cells to initiate intracellular signaling events. However, the widely accepted model of cyclical GDP-GTP exchange in response to ligand binding to 7TMRs, followed by dissociation of the G protein subunits and activation of intracellular signaling cascades, has repeatedly been challenged in recent years. Some of the exceptions that have been brought forth include signaling by a non-dissociated, rearranged heterotrimer and the existence of “reverse-mode”, active G proteins that interact with active receptors. Here, we focus on Gαi/o, one of the common Gα classes, and outline a major exception to the classical model, that of G protein coupling to RTKs. We then describe a novel concept in Gαi/o signaling, namely that the pathways induced by agonist binding circumvent the typical signaling pathways responsive to decreases in the second messenger cAMP, via adenylyl cyclase inhibition.
Keywords: Adenylyl-cyclase independent, Gαi, G protein-coupled receptors, receptor tyrosine kinase.
Current Vascular Pharmacology
Title:Atypical Gαi Signal Transduction
Volume: 12 Issue: 2
Author(s): Raissa Perrault and Peter Zahradka
Affiliation:
Keywords: Adenylyl-cyclase independent, Gαi, G protein-coupled receptors, receptor tyrosine kinase.
Abstract: G protein signaling is an extremely complex event that is involved in almost every cellular process. As such, G protein-coupled receptors are the most commonly found type of transmembrane receptors used by cells to initiate intracellular signaling events. However, the widely accepted model of cyclical GDP-GTP exchange in response to ligand binding to 7TMRs, followed by dissociation of the G protein subunits and activation of intracellular signaling cascades, has repeatedly been challenged in recent years. Some of the exceptions that have been brought forth include signaling by a non-dissociated, rearranged heterotrimer and the existence of “reverse-mode”, active G proteins that interact with active receptors. Here, we focus on Gαi/o, one of the common Gα classes, and outline a major exception to the classical model, that of G protein coupling to RTKs. We then describe a novel concept in Gαi/o signaling, namely that the pathways induced by agonist binding circumvent the typical signaling pathways responsive to decreases in the second messenger cAMP, via adenylyl cyclase inhibition.
Export Options
About this article
Cite this article as:
Perrault Raissa and Zahradka Peter, Atypical Gαi Signal Transduction, Current Vascular Pharmacology 2014; 12 (2) . https://dx.doi.org/10.2174/1570161112666140226122512
DOI https://dx.doi.org/10.2174/1570161112666140226122512 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
"New Frontiers in Cardiovascular and Hematologic Disease Treatment: Exploring and Applying Natural Drug Targets"
Cardiovascular and hematologic diseases are among the most pressing global health challenges, placing a heavy burden on public health systems worldwide. As research progresses, novel therapeutic targets continue to be identified, offering new possibilities for treating these complex conditions. However, despite advancements in current therapies, more integrated research approaches are ...read more
Advancements in Arterial Stiffness: Novel Therapeutic Frontiers
Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Therapeutic Applications of Advanced Drug Delivery Systems)
Current Pharmaceutical Design Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Aptamers as Therapeutics in Cardiovascular Diseases
Current Medicinal Chemistry Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis
Current Vascular Pharmacology Artificial Intelligence against COVID-19 Pandemic: A Comprehensive Insight
Current Medical Imaging Diet and Sudden Death: How to Reduce the Risk
Current Vascular Pharmacology Status Epilepticus in the Immature Rodent Brain Alters the Dynamics of Autophagy
Current Neurovascular Research A Comparative Study of Marketing Authorization of Drug Eluting Coronary Stents (DES) in India and Developed Countries (USA & EU)
Applied Clinical Research, Clinical Trials and Regulatory Affairs Novel Perspective for Antithrombotic Therapy in TAVI
Current Pharmaceutical Design Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Receiving Thrombectomy: Standard or Low Dose Therapy?
Current Neurovascular Research Heart Failure with Preserved Ejection Fraction: Entresto a Possible Option
Cardiovascular & Hematological Disorders-Drug Targets The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors
CNS & Neurological Disorders - Drug Targets Depression-like Behavior Induced by Repeated Administration of Dexamethasone to Lipopolysaccharide-inflamed Mice
Current Molecular Pharmacology Not Simply a Matter of Fish Intake
Current Vascular Pharmacology Is Colchicine Involved in Managing Stroke?
Current Vascular Pharmacology Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
Current Cardiology Reviews A Sustainable Approach Towards Prevention and Treatment of Hepatic and Other Disorders Associated with Alcohol Consumption
Current Drug Therapy SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics
Mini-Reviews in Medicinal Chemistry The ACE2-Ang-(1-7)-Mas Axis and Cardioprotection
Current Cardiology Reviews